Quick Answer
X4 Pharmaceuticals, Inc reported Net Income of -$79.20 million for fiscal year 2025.
X4 Pharmaceuticals, Inc Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$79.20M | -111.5% |
| 2024 | -$37.45M | +63.0% |
| 2023 | -$101.17M | -7.8% |
| 2022 | -$93.87M | -5.8% |
| 2021 | -$88.70M | -42.8% |
| 2020 | -$62.13M | -17.7% |
| 2019 | -$52.81M | -58.7% |
| 2018 | -$33.28M | -51.3% |
| 2017 | -$21.99M | +4.3% |
| 2016 | -$22.98M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$29.82M | +18.8% | -15.8% |
| June 30, 2025 | -$25.74M | -128.3% | -9228.0% |
| March 31, 2025 | $282.0K | +100.5% | +100.8% |
| September 30, 2024 | -$36.70M | -1492.0% | -140.4% |
| June 30, 2024 | $90.83M | +263.0% | +275.5% |
| March 31, 2024 | -$51.77M | -115.5% | -2145.8% |
| September 30, 2023 | -$2.31M | +89.3% | +95.9% |
| June 30, 2023 | -$55.71M | -162.6% | -131.9% |
- X4 Pharmaceuticals, Inc showed a decrease of -111.5% in Net Income compared to the prior fiscal year.
- Over the 2016–2025 period, X4 Pharmaceuticals, Inc’s net income has declined by 244.7% (from -$22.98 million to -$79.20 million).
- The most recent figure is from X4 Pharmaceuticals, Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: